Looks like an exciting 2013 from the J.P. Morgan Healthcare Conference

>
35 of 40
<

Jean-Jacques Bienaime, CEO of BioMarin

Jean-Jacques Bienaime, CEO of BioMarin, was in San Francisco to talk about the company's rare-disease strategy.